Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
10/2012
10/17/2012CN102731659A 6*His-C99recombinant protein, and preparation method and application thereof
10/17/2012CN102731658A Tat PTD-Endostatin recombination protein, preparation method and application thereof
10/17/2012CN102080098B Eukaryon expression vector and application thereof to preparing medicament for inhibiting leukemia cell proliferation
10/17/2012CN101967195B Thrombolysis-targeting fusion protein mAnxB1ScuPA, structure and application thereof
10/17/2012CN101691405B Fusion antigen uses as vaccine
10/16/2012US8288518 Rearranged squamous cell carcinoma antigen genes
10/16/2012US8287884 Staphylococcus aureus proteins and nucleic acids
10/16/2012US8287866 Methods of treating IL-TIF associated inflammatory or immune diseases using antibodies against soluble zcytor 11 cytokine receptors
10/16/2012CA2451847C A novel engineered superantigen for human therapy
10/16/2012CA2404340C Methods of blocking tissue destruction by autoreactive t cells
10/11/2012WO2012139112A1 Ubiquitin fusions for improving the efficacy of cytosolic acting targeted toxins
10/11/2012WO2012139086A2 Single chain antibodies for photosynthetic microorganisms and methods of use
10/11/2012WO2012138235A2 Local demand side power management for electric utility networks
10/11/2012WO2012137970A1 Modified laminin and use thereof
10/11/2012WO2012136737A1 Quantitative standard for mass spectrometry of proteins
10/11/2012WO2012074330A3 Fusion peptide comprising dhfas-1 domain and mmp substrate and use thereof for preventing and treating rheumatoid arthritis
10/11/2012US20120259101 Isopeptide Bond Formation in Bacillus Species and Uses Thereof
10/11/2012US20120258920 Peptides and aptamers thereof as specific modulators of mutant p53 function
10/11/2012US20120258515 Cytolytic RTX-Toxin From Gallibacterium Anatis
10/11/2012US20120258106 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells
10/11/2012US20120258105 Methods and compositions to regulate iron metabolism
10/11/2012US20120258104 Delivery System and Conjugates For Compound Delivery Via Naturally Occurring Intracellular Transport Routes
10/11/2012US20120258072 Interleukin-11 Fusion Proteins
10/11/2012US20120258071 Compositions and Methods of Use for MGD-CSF in Disease Treatment
10/11/2012CA2835606A1 Single chain antibodies for photosynthetic microorganisms and methods of use
10/11/2012CA2832569A1 Reversing the effects of the tumor microenvironment using chimeric cytokine receptors
10/11/2012CA2832115A1 Pepducin design and use
10/11/2012CA2831998A1 Quantitative standard for mass spectrometry of proteins
10/10/2012EP2508537A1 Quantitative standard for mass spectrometry of proteins
10/10/2012EP2507267A1 Compositions and methods for increasing serum half-life of fc fusion proteins
10/10/2012EP2507266A2 TREATMENT OF IgE-MEDIATED DISEASE
10/10/2012CN1522156B Novel engineered superantigen for human therapy
10/10/2012CN1371416B Human CTLA-4 antibodies and their uses
10/10/2012CN102725412A Optimized endonucleases and uses thereof
10/10/2012CN102725312A Protein agent for diabetes treatment and beta cell imaging
10/10/2012CN102725311A Methods of treating inflammation
10/10/2012CN102719468A Method for inducing protein to form amyloid fiber through fibration segment
10/10/2012CN102718873A Mycobacterium tuberculosis specific fusion protein as well as preparation and application of mycobacterium tuberculosis specific fusion protein
10/10/2012CN102718872A Bacillus thuringiensis gene combination and engineering bacteria and preparation method thereof
10/10/2012CN102718871A Recombinant protein of mycobacterium tuberculosis specific marker Rv 1284, preparation method and application thereof
10/10/2012CN102718870A Insulin bio-sensitizer and application thereof
10/10/2012CN102153654B Branched polypeptide using immune active peptide as vector and derivatives and application of branched polypeptide
10/10/2012CN101899469B Shuttle plasmid and method for efficiently expressing cecropin and lysozyme genes
10/10/2012CN101857636B Anti-interferon-alpha antibodies
10/10/2012CN101351550B Chimaeric fusion protein with superior chaperone and folding activities
10/10/2012CN101287484B Binding agents which inhibit myostatin
10/09/2012US8283138 Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins
10/09/2012US8282935 Intensify immunology response; administering epitopes; polynucleotide sequences
10/09/2012CA2466474C Compositions comprising spa-1, spa-2 and spa-3, polypeptides and related uses
10/09/2012CA2455830C Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
10/09/2012CA2243845C Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
10/04/2012WO2012135284A2 Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes
10/04/2012WO2012135177A2 Methods and compositions for cytomegalovirus il-10 protein
10/04/2012WO2012131491A1 Compositions and methods for analysis of h3k4 methylated chromatin
10/04/2012WO2012130136A1 Glucagon-like peptide-1 analogue monomer and dimer, preparation method therefor and application thereof
10/04/2012WO2012107416A3 Improved immunotherapy
10/04/2012WO2012083445A8 Virus like particle production in plants
10/04/2012WO2012078906A3 Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
10/04/2012WO2012053823A9 Fusion protein having factor ix activity
10/04/2012US20120253023 Hybrid polypeptides with selectable properties
10/04/2012US20120253009 Thrombopoietic compounds
10/04/2012US20120252884 Modified and Stabilized GDF Propeptides and Uses Thereof
10/04/2012US20120252742 Human Single-Chain T Cell Receptors
10/04/2012US20120252732 Albumin fusion proteins
10/04/2012US20120252717 Conjugates of biologically active proteins having a modified in vivo half-life
10/04/2012US20120252698 Isolated australian coral reef fluorescent proteins and cell-based kinase or phosphatase platforms for cancer drug development
10/04/2012US20120252097 Therapeutic Agents Comprising Pro-Apoptotic Proteins
10/04/2012US20120251541 Dual Variable Region Antibody-Like Binding Proteins Having Cross-Over Binding Region Orientation
10/04/2012US20120251531 ANTIBODY Fc VARIANTS
10/04/2012US20120251446 Peptide Conjugates Comprising Polyhistidine Sequence and Free Cysteine and Their Uses in Imaging
10/03/2012EP2504027A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors
10/03/2012CN102712697A Vault complexes for cytokine delivery
10/03/2012CN102711791A HIV related peptides combination or fusion for use in HIV vaccine composition or as diagnostic means
10/03/2012CN102703483A Recombinant oral protein TAT-GH of tilapia, preparation method for recombinant oral protein TAT-GH and application of recombinant oral protein TAT-GH
10/03/2012CN102703401A Phosphotriesterase from agrobacterium radiobacter p230
10/03/2012CN102702360A Novel mycobacterium tuberculosis specific fusion protein as well as preparation and application thereof
10/03/2012CN102702324A Application of human procalcitonin B cell epitope peptide fragment and monoclonal antibody thereof
10/03/2012CN102702323A Application of procalcitonin B cell epitope peptide fragment and monoclonal antibody thereof
10/03/2012CN101899461B Fusion gene capable of encoding influenza A virus NP protein and M2e polypeptide
10/03/2012CN101891823B Exendin-4 and analog fusion protein thereof
10/03/2012CN101668778B Preparation of low bleeding anticoagulant fusion protein and its use
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278098 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/02/2012US8278066 Truncated somatostatin receptors
10/02/2012CA2711007C G-csf analog compositions and methods
10/02/2012CA2430135C Recombinant anti-cd30 antibodies and uses thereof
10/02/2012CA2396534C Intrabodies with defined framework that is stable in a reducing environment and applications thereof
10/02/2012CA2223269C Hepatocyte growth factor receptor antagonists and uses thereof
09/2012
09/27/2012WO2012129449A2 High level production of recombinant proteins
09/27/2012WO2012128722A2 Recombinant protein biosensors and a method for detecting the presence of an analyte molecule
09/27/2012WO2012128580A1 Water-soluble polypeptides comprised of repeat modules, method for preparing the same and method for a target-specific polypeptide and analysis of biological activity thereof
09/27/2012WO2012127739A1 Novel carrier molecule and method both for delivering rna into cytoplasm using near-infrared light
09/27/2012WO2012127047A1 Constructs and method for regulating gene expression or for detecting and controlling a dna locus in eukaryotes
09/27/2012WO2012126879A1 Novel oprf/i fusion proteins, their preparation and use
09/27/2012WO2012126172A1 Peptides inhibiting adhesion of aspergillus fumigatus to cornea
09/27/2012WO2012126157A1 Annexin v variant, and preparation and use thereof
09/27/2012WO2012126149A1 Mycobacterium tuberculosis fusion protein and its preparation method and use thereof
09/27/2012WO2012126118A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
09/27/2012WO2012097093A3 Novel wnt compositions and therapeutic uses of such compositions
09/27/2012US20120245332 Mhc oligomers, components thereof, and methods of making the same
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 295